Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C47H51NO14 |
Molecular Weight | 853.9061 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 11 / 11 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7
InChI
InChIKey=RCINICONZNJXQF-MZXODVADSA-N
InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1
Molecular Formula | C47H51NO14 |
Molecular Weight | 853.9061 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 10 / 11 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:18:43 UTC 2023
by
admin
on
Fri Dec 15 15:18:43 UTC 2023
|
Record UNII |
P88XT4IS4D
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
270208
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
50190
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
NDF-RT |
N0000175085
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
LIVERTOX |
NBK548093
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
394813
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
NCI_THESAURUS |
C67437
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/06/422
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
454014
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
WHO-VATC |
QL01CD01
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
594217
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
469915
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
103497
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
186404
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
482015
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
NDF-RT |
N0000175592
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
278309
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.2
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
384912
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
104797
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
454114
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PAXENE (WITHDRAWN: OVARIAN NEOPLASMS)
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
CFR |
21 CFR 516.1684
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
290709
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
252907
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
NCI_THESAURUS |
C1490
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
WHO-ATC |
L01CD01
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ABRAXANE (AUTHORIZED: PANCREATIC NEOPLASMS)
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
291009
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PAXENE (WITHDRAWN: CARCINOMA, NON-SMALL-CELL LUNG)
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
141701
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
280409
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
33069-62-4
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
100000085474
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
P88XT4IS4D
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
EE-62
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
45863
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
D017239
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
6839
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
125973
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
CHEMBL428647
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
DTXSID9023413
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
DB01229
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
2770
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
P88XT4IS4D
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
7052
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
PACLITAXEL
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
1491332
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
56946
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
SUB09583MIG
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
C1411
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
36314
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
m8351
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | Merck Index | ||
|
Paclitaxel
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
C495179
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
2044
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
PRIMARY | |||
|
486610
Created by
admin on Fri Dec 15 15:18:43 UTC 2023 , Edited by admin on Fri Dec 15 15:18:43 UTC 2023
|
ALTERNATIVE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> SUBSTRATE | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
TRANSPORTER -> INHIBITOR | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
METABOLIC ENZYME -> INDUCER | |||
|
TRANSPORTER -> INDUCER |
Paclitaxel activates pregnane X receptor (PXR)
|
||
|
TRANSPORTER -> INHIBITOR |
|
||
|
METABOLIC ENZYME -> INDUCER |
Paclitaxel activates pregnane X receptor (PXR)
|
||
|
TRANSPORTER -> SUBSTRATE |
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
TRANSPORTER -> INHIBITOR | |||
|
TRANSPORTER -> SUBSTRATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE | |||
|
METABOLITE -> PARENT |
In vitro studies with human liver microsomes and tissue slices showed that paclitaxel was metabolized primarily to 6α-hydroxypaclitaxel by CYP2C8; and to two minor metabolites, 3'-p-hydroxypaclitaxel and 6α, 3'-p-dihydroxypaclitaxel, by CYP3A4.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||